Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretin Therapy During Ex-Situ Normothermic Liver Machine Perfusion
NCT07651748Phase 2Enrolling by invitation
- Sponsor
- Erasmus MC
- Start
- Apr 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of secretin in liver disease, sponsored by Erasmus MC. Started Apr 2025; status: enrolling by invitation.
02
Drugs
secretin
03
Conditions
liver disease
Beyond the preview
Go deeper on NCT07651748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07651748.